Verily Life Sciences, Alphabet’s health-focused subsidiary and formerly Google Life Sciences, unveiled last week its Verily Study Watch, a health tracking watch for use as an investigational device.
In a blog post, David He, technical lead, Tushar Parlikar, product manager and Harry Xiao, technical program manager at Verily, write that the Smart Watch represents another step in the company’s targeted efforts to “create new tools for unobtrusive biosensing.” And Verily says there is a need for the scalable collection of rich and complex datasets across clinical and observational studies.
Check out the full article here: Google’s Verily Unveils Health Watch for Medical Research
Welcome to Clinical Research Trends, a new blog dedicated to providing breaking news on clinical trial recruitment, patient engagement, new technology and noteworthy trends. With this blog, we are working to provide clinical research organizations, sponsors and leading service providers with critical news and industry updates on a regular basis. If you want to learn more about the latest trends in clinical trial recruitment and drug development, you’ve come to the right place.